| Full Name | Randy Barnhard |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 275 Sandwich St, Plymouth, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811373855 | NPI | - | NPPES |
| 110123741A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN2300189 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Hospital Plymouth | Plymouth, MA | Hospital |
| Falmouth Hospital | Falmouth, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cape Cod Anesthesia Associates, Inc | 0749260933 | 37 |
| Capa Anesthesia Llc | 1850786393 | 48 |
| Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is | 6305749987 | 440 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Cape Cod Anesthesia Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659308021 PECOS PAC ID: 0749260933 Enrollment ID: O20040720000910 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Millennium Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154340305 PECOS PAC ID: 3870559461 Enrollment ID: O20041206000597 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Cap Anesthesia, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497763213 PECOS PAC ID: 8820090269 Enrollment ID: O20070214000051 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Ether Anesthesia Of Massachusetts Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184172769 PECOS PAC ID: 3476833492 Enrollment ID: O20161209000532 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1245773308 PECOS PAC ID: 6305749987 Enrollment ID: O20170628003015 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Massachusetts Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457867020 PECOS PAC ID: 8820350713 Enrollment ID: O20180312001704 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Entity Name | Capa Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629723002 PECOS PAC ID: 1850786393 Enrollment ID: O20220318000777 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randy Barnhard, 275 Sandwich St, Plymouth, MA 02360-2183 Ph: (085) 746-2000 | Randy Barnhard, 275 Sandwich St, Plymouth, MA 02360 Ph: (085) 746-2000 |
News Archive
Twenty-two physical symptoms associated with cancer - symptoms often unrecognized and undertreated - are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a cancer survivor, according to researchers from the Regenstrief Institute and the Indiana University schools of medicine and nursing.
With the number of influenza A H1N1 (swine flu) cases in Australia now over 300 federal Health Minister Nicola Roxon says the government is considering whether to elevate the nation's response to the disease from the contain to sustain phase, as it may be impossible to keep quarantining people.
ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
› Verified 7 days ago
Patrick Linehan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-830-2113 | |
Elizabeth Wittenstein, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 | |
Robert Gauvin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 | |
Rachel M Hammerschmidt, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 176-673-1106 Fax: 617-754-8791 | |
Victoria Gohh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-746-2000 | |
Mr. John C. Cona, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-746-2000 | |
Diane R Bauer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 275 Sandwich St, Plymouth, MA 02360 Phone: 508-830-2113 Fax: 781-407-0998 |